{"id":463,"date":"2014-04-14T20:45:40","date_gmt":"2014-04-14T20:45:40","guid":{"rendered":"https:\/\/kefea.org.cy\/board-2\/"},"modified":"2023-05-02T14:35:41","modified_gmt":"2023-05-02T14:35:41","slug":"board","status":"publish","type":"page","link":"https:\/\/kefea.org.cy\/el\/board\/","title":{"rendered":"\u0394\u03b9\u03bf\u03b9\u03ba\u03b7\u03c4\u03b9\u03ba\u03cc \u03a3\u03c5\u03bc\u03b2\u03bf\u03cd\u03bb\u03b9\u03bf"},"content":{"rendered":"

[et_pb_section fb_built=”1″ inner_shadow=”on” fullwidth=”on” admin_label=”section” _builder_version=”3.22″ background_color=”#ac3d70″ background_image=”https:\/\/kefea.org.cy\/wp-content\/uploads\/2014\/04\/bg_plain.gif”][et_pb_fullwidth_header title=”\u0394\u03b9\u03bf\u03b9\u03ba\u03b7\u03c4\u03b9\u03ba\u03cc \u03a3\u03c5\u03bc\u03b2\u03bf\u03cd\u03bb\u03b9\u03bf” content_max_width=”none” admin_label=”Fullwidth Header” _builder_version=”3.16″ background_color=”rgba(255, 255, 255, 0)” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”] [\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”3.22″][et_pb_row admin_label=”row” _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/kefea.org.cy\/wp-content\/uploads\/2014\/04\/board_tit.jpg” align_tablet=”center” align_phone=”” align_last_edited=”on|desktop” admin_label=”Image” _builder_version=”3.23″ animation_style=”slide” animation_direction=”left” animation_duration=”500ms” animation_intensity_slide=”10%” animation=”left”] [\/et_pb_image][et_pb_text admin_label=”Text” _builder_version=”4.9.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u038c\u03bd\u03bf\u03bc\u03b1<\/strong><\/td>\n\u03a4\u03af\u03c4\u03bb\u03bf\u03c2<\/strong><\/td>\nEmail<\/strong><\/td>\n<\/tr>\n
\u039a\u03c5\u03c1\u03b9\u03ac\u03ba\u03bf\u03c2 \u039c\u03b9\u03ba\u03ad\u03bb\u03bb\u03b7\u03c2
<\/strong>\u03a0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2<\/td>\n		\n

Pfizer Hellas Cyprus Branch\u00a0<\/strong><\/p>\n

Cyprus & Malta Lead<\/p>\n<\/td>\n

kyriakos.mikellis@pfizer.com<\/a><\/td>\n<\/tr>\n
Jacqueline Anastassiades
<\/strong>\u0391\u03bd\u03c4\u03b9\u03c0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2<\/td>\n		Merck Sharp & Dohme Cyprus Ltd<\/strong>
Cyprus \/ Malta Managing Director<\/td>\n		jacqueline_anastassiades@merck.com<\/a><\/td>\n<\/tr>\n
\u03a6\u03af\u03bb\u03b9\u03c0\u03c0\u03bf\u03c2 \u039c\u03bf\u03c5\u03c7\u03b5\u03bb\u03b7\u03c2<\/strong><\/td>\n\n

Sanofi<\/strong>\u00a0– Aventis Cyprus Ltd<\/strong><\/p>\n

Country Head of Trade<\/p>\n<\/td>\n

filippos.mouhelis@sanofi.com<\/a><\/td>\n<\/tr>\n
\n

Fabio Sperandei<\/strong><\/p>\n<\/td>\n

\n

Novartis Pharma Services Inc<\/strong><\/p>\n

Country President Innovative Medicine<\/p>\n<\/td>\n

fabio.sperandei@novartis.com<\/a>\u00a0<\/td>\n<\/tr>\n
\u039c\u03b1\u03c1\u03c9 \u0393\u03c1\u03b7\u03b3\u03bf\u03c1\u03af\u03bf\u03c5
<\/strong><\/td>\n		\n

Eli Lilly (Suisse) S.A.<\/strong><\/p>\n

Cyprus\/Malta Country Manager<\/p>\n<\/td>\n

gregoriou_maro@lilly.com<\/a><\/td>\n<\/tr>\n
\u039d\u03b9\u03ba\u03cc\u03bb\u03b1\u03bf\u03c2 \u039b\u03b9\u03b1\u03ba\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2<\/strong><\/td>\n\n

Amgen Hellas EPE<\/strong><\/p>\n

Medical Development Sr Manager<\/p>\n<\/td>\n

lnick@amgen.com<\/a>\u00a0<\/td>\n<\/tr>\n
\u0391\u03bd\u03c4\u03ce\u03bd\u03b7\u03c2 \u039b\u03bf\u03c5\u03c1\u03bf\u03c5\u03c4\u03b6\u03b9\u03ac\u03c4\u03b7\u03c2<\/strong><\/td>\n\n

Genesis Pharma (Cyprus) Limited<\/strong><\/p>\n

Country Lead<\/p>\n

<\/strong><\/p>\n<\/td>\n

alouroutziatis@genesispharma.com<\/a><\/td>\n<\/tr>\n
\u0393\u03b9\u03ce\u03c4\u03b1 \u039a\u03bf\u03c4\u03c3\u03b5\u03ba\u03af\u03b4\u03bf\u03c5<\/strong><\/td>\n\n

AstraZeneca SA<\/strong><\/p>\n

External Affairs Director<\/p>\n<\/td>\n

\u00a0GIota.Kotsekidou@astrazeneca.com<\/a> \u00a0\u00a0<\/a><\/td>\n<\/tr>\n
\u03a7\u03b1\u03c1\u03ac\u03bb\u03b1\u03bc\u03c0\u03bf\u03c2 \u039b\u03ac\u03bc\u03c0\u03c1\u03bf\u03c5<\/strong><\/td>\n\n

Astellas Pharmaceuticals<\/strong><\/p>\n

General Manager Greece, Cyprus & Malta<\/p>\n<\/td>\n

\n

charalampos.lamprou@astellas.com<\/a>\u00a0<\/p>\n

 <\/p>\n<\/td>\n<\/tr>\n

\u0395\u03c1\u03c9\u03c4\u03cc\u03ba\u03c1\u03b9\u03c4\u03bf\u03c2 \u039c\u03bf\u03c5\u03b6\u03ac\u03ba\u03b7\u03c2<\/strong><\/td>\n\n

Bristol-Myers Squibb S.A.<\/strong>\u00a0<\/p>\n

Pricing & Reimbursement Manager<\/p>\n<\/td>\n

\u00a0erotokritos.mouzakis@bms.com<\/a><\/td>\n<\/tr>\n
\u039f\u03bb\u03cd\u03bc\u03c0\u03b9\u03bf\u03c2 \u03a0\u03b1\u03c0\u03b1\u03b4\u03b7\u03bc\u03b7\u03c4\u03c1\u03af\u03bf\u03c5<\/strong><\/td>\n\n

Novo Nordisk Ltd<\/b><\/p>\n

General Manager<\/p>\n<\/td>\n

opap@novonordisk.com<\/a>\u00a0<\/td>\n<\/tr>\n
\u0393\u03c1\u03b7\u03b3\u03cc\u03c1\u03b7\u03c2 \u03a0\u03bf\u03bb\u03af\u03c4\u03b7\u03c2<\/strong><\/td>\n\n

MENARINI HELLAS AE<\/b><\/p>\n<\/td>\n

<\/a>gpolitis@menarini.gr<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

  \u038c\u03bd\u03bf\u03bc\u03b1 \u03a4\u03af\u03c4\u03bb\u03bf\u03c2 Email \u039a\u03c5\u03c1\u03b9\u03ac\u03ba\u03bf\u03c2 \u039c\u03b9\u03ba\u03ad\u03bb\u03bb\u03b7\u03c2\u03a0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 Pfizer Hellas Cyprus Branch\u00a0 Cyprus & Malta Lead kyriakos.mikellis@pfizer.com Jacqueline Anastassiades\u0391\u03bd\u03c4\u03b9\u03c0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 Merck Sharp & Dohme Cyprus LtdCyprus \/ Malta Managing Director jacqueline_anastassiades@merck.com \u03a6\u03af\u03bb\u03b9\u03c0\u03c0\u03bf\u03c2 \u039c\u03bf\u03c5\u03c7\u03b5\u03bb\u03b7\u03c2 Sanofi\u00a0– Aventis Cyprus Ltd Country Head of Trade filippos.mouhelis@sanofi.com Fabio Sperandei Novartis Pharma Services Inc Country President Innovative Medicine fabio.sperandei@novartis.com\u00a0 \u039c\u03b1\u03c1\u03c9 \u0393\u03c1\u03b7\u03b3\u03bf\u03c1\u03af\u03bf\u03c5 Eli Lilly (Suisse) […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-463","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/pages\/463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/comments?post=463"}],"version-history":[{"count":36,"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/pages\/463\/revisions"}],"predecessor-version":[{"id":2789,"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/pages\/463\/revisions\/2789"}],"wp:attachment":[{"href":"https:\/\/kefea.org.cy\/el\/wp-json\/wp\/v2\/media?parent=463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}